acquired
Stage
1
Investors
About
Synthetic Genomics is a synthetic biology company that uses proprietary technology to design and build biological systems aimed at solving global sustainability challenges.
Explore Synthetic Genomics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.